Monday, July 22, 2019

Structural Heart Devices Market - Latest Trends, Growth, Opportunities and Forecast 2027

According to research report the global structural heart devices market is expected to reach USD 19.6 billion by 2027 from USD 10.4 billion in 2019, at a CAGR of 8.2%. Growth in the structural heart devices market is mainly driven by factors such as the rising prevalence of structural heart diseases, regulatory approvals for new and advanced structural heart devices, favourable reimbursement scenario for structural heart procedures & devices, and increasing awareness about structural heart diseases.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=161123753
Objectives of the Study:
• To define, describe, and forecast the global structural heart devices market, by product, procedure, and region
• To provide detailed information regarding factors influencing market growth (drivers, restraints, opportunities, and challenges)
• To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape of market leaders
• To forecast the size of the structural heart devices market in North America, Europe, Asia Pacific, and the Rest of the World
• To profile the key players in the global structural heart devices market and comprehensively analyze their core competencies
• To track and analyze competitive developments, such as product launches & approvals, acquisitions, expansions, and partnerships & agreements, of the leading players in the structural heart devices market
The report describes and studies the global structural heart devices market, by product, procedure, and region.
It provides detailed information regarding the major factors influencing the growth of this market and the regulatory analysis impacting market dynamics.
On the basis of product, the global structural heart devices market is segmented into heart valve devices, occluders and delivery systems, annuloplasty rings, other devices, and accessories. The heart valve devices segment is expected to register the highest CAGR during the forecast period. The high growth of this segment can be attributed to the growing number of trans catheter aortic valve replacement procedures performed across the globe, the efficacy and durability of these products, and the growing number of regulatory approvals for heart valve devices.
Get Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=161123753
North America is expected to dominate the structural heart devices market during the forecast period
Geographically, North America is expected to account for the largest share of the structural heart devices market in 2018, followed by Europe. The large share of North America in the global market is attributed to factors such as the rising prevalence of structural heart diseases, favourable reimbursement scenario for structural heart procedures and devices, technological advancements, and development of innovative devices.
Edwards Lifesciences Corporation (US), Medtronic plc (Ireland), Abbott (US), Boston Scientific Corporation (US), and LivaNova plc (UK) are the key players in the structural heart devices market. The other players in this market are CryoLife, Inc. (US), Micro Interventional Devices, Inc. (US), Braile Biomédica (Brazil), Lepu Medical Technology (Beijing) Co., Ltd. (China), and TTK Healthcare Limited (India).

Friday, July 19, 2019

Spirometer Market – Know the Business Growth Opportunities



According to research report the global Spirometer Market is expected to reach USD 1,047 million by 2023 from USD 655 million in 2018, at a CAGR of 9.8%.
The report studies the market on the basis of product type, mechanism, application, end user, and region. Market growth is largely driven by the rising global incidence of respiratory diseases, global population, and technological advancements in spirometer devices.
By product type, the spirometry equipment market is segmented into consumables & accessories, devices, and software. The consumables & accessories segment accounted for the largest share in 2018. The rising incidence of respiratory diseases and the growing geriatric population are the key factors driving the growth of this product segment.
Based on application, the spirometry equipment market is segmented into COPD, asthma, and other applications. Among these, the COPD segment accounted for the largest share of the spirometry equipment market in 2018. The large share of this segment is mainly due to the high and growing prevalence of COPD globally and the easy diagnosis of COPD offered by spirometry.
By end user, the spirometry equipment market is segmented into hospitals, clinical laboratories, home care settings, and industrial settings. Hospitals accounted for the largest share of the spirometry equipment market in 2018 while the home care settings segment is expected to register the highest growth during the forecast period. The growing requirement for personalized lung monitoring is a key factor driving the growth of the spirometry equipment market for home care settings.
The spirometry equipment market is geographically segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). Asia is expected to register the highest CAGR in the market during the forecast period. The high growth in this region can primarily be attributed to the rising geriatric population, high burden of respiratory diseases such as COPD and asthma, growing per capita income, increasing investments in the healthcare industry by key market players, rising demand for cutting-edge technologies, expansion of private-sector hospitals to rural areas in various APAC countries, and the presence of high-growth markets such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore.
Key players in this market can explore the possibilities of expanding to the emerging economies of India and Brazil. These countries are going through a phase of rapid industrialization, leading to increasing pollution levels. This has created a need for monitoring lung conditions regularly, which increases the demand for spirometers.

Thursday, July 18, 2019

Hyperspectral Imaging Systems - Know the Market Growth and Business Opportunities



According to research report the global hyperspectral imaging systems market is projected to reach USD 21.33 billion by 2023 from USD 9.51 billion in 2018, at a CAGR of 17.5%.
The growing industrial applications of hyperspectral imaging and increasing funding & investments are the major factors driving the growth of the global hyperspectral imaging systems market. However, data storage issues and high costs associated with the use of hyperspectral imaging are expected to restrain the growth of this market during the forecast period.
The hyperspectral imaging systems market is categorized into two product segments, namely, cameras and accessories. The cameras segment is expected to command the largest share of the global hyperspectral imaging systems market in 2018. Factors such as recent advances in sensor development and computing power and the availability of low-cost cameras with widening industrial applications are driving the growth of this market segment.
On the basis of application, the hyperspectral imaging systems market is segmented into military surveillance, remote sensing, machine vision & optical sorting, life sciences & medical diagnostics, and other applications. The life sciences and medical diagnostics segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to various advantages associated with hyperspectral imaging, such as early detection of various types of cancer and retinal diseases.
On the basis of remote sensing application, the hyperspectral imaging systems market is segmented into agriculture, environmental monitoring, mining/mineral mapping, and other remote sensing applications. The agriculture segment is expected to grow at the highest CAGR during the forecast period.
Among the four regional segments covered in the hyperspectral imaging market—North America, Europe, Asia Pacific, and the Rest of the World (RoW), Asia Pacific is expected to register the highest CAGR during the forecast period. Factors such as technological advancements have resulted in the development of cost-effective hyperspectral imaging systems, which are being used in several commercial applications in the price-sensitive Asia Pacific region. Also, the emerging economies in Asia Pacific and Latin America are expected to offer significant growth opportunities for players in the hyperspectral imaging systems market.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
newsletter@marketsandmarkets.com

Wednesday, July 17, 2019

Life Science Analytics Market worth $33.2 billion by 2024



According to research the research report Life Science Analytics Market is projected to reach USD 33.2 billion by 2024 from USD 19.3 billion in 2019, at a CAGR of 11.5% during the forecast period. Growth in this market is mainly driven by technological advancements, big data in the life science industry, growing adoption of analytics solutions in clinical trials, increasing adoption of analytics for sales and marketing applications, need for improved data standardization, increasing prevalence of chronic diseases, growing pressure to curb healthcare spending, and the need for improved patient outcomes. On the other hand, high implementation costs are expected to restrain the growth of this market to a certain extent.
“The on-demand model segment is expected to grow at the highest CAGR during the forecast period.”
Based on delivery model, the life science analytics market is segmented into the on-demand model and on premise model. The on-demand model segment is expected to grow at the highest CAGR during the forecast period, owing to advantages such as growing demand for self-driven analytics, lack of upfront capital investments for hardware, extreme capacity flexibility, and pay-as-you-go pricing of this model.
“The descriptive analytics segment accounted for the largest market share in 2018.”
Based on type, the life science analytics market is segmented into descriptive analytics, predictive analytics, and prescriptive analytics. The descriptive analytics segment accounted for the largest share of the life science analytics market in 2018. The large share of this segment is attributed to the significant usage of descriptive analytics by stakeholders to gain a better understanding of the past trends and events occurring in real-time.
 “North America commanded the largest share of the life science analytics market in 2018.”
In 2018, North America accounted for the largest market share, followed by Europe. The large share of this market can primarily be attributed to the strong economies in the US and Canada, which have allowed for significant investments in technology in this region. Growth in the North American market is supported by the growing adoption of IT in the life science industry, rising pressure to reduce healthcare costs, stringent regulations for the pharma-biotech and medical device industries, and the greater product and service availability in this region.
The prominent players in the life science analytics market are IBM Corporation (US), Oracle Corporation (US), SAS Institute, Inc. (US),  Quintiles, Inc. (US), Accenture (Ireland), Cognizant (US), Wipro Limited (India), MaxisIT, Inc. (US), TAKE Solutions (India), and SCIO Health Analytics (US).

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
newsletter@marketsandmarkets.com